中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2010年
4期
270-272
,共3页
莫武宁%王湛%周玲%詹少兵%唐安洲%黄光武%曾毅
莫武寧%王湛%週玲%詹少兵%唐安洲%黃光武%曾毅
막무저%왕담%주령%첨소병%당안주%황광무%증의
腺病毒科%疱疹病毒4型,人%病毒包膜蛋白质类%树突状细胞%肿瘤抑制蛋白质类
腺病毒科%皰疹病毒4型,人%病毒包膜蛋白質類%樹突狀細胞%腫瘤抑製蛋白質類
선병독과%포진병독4형,인%병독포막단백질류%수돌상세포%종류억제단백질류
Adenovirus%Herpesvirus 4,human%Viralenvelope proteins%Dendritic cells%Tumor suppressor proteins
目的 了解含有EB病毒潜伏膜蛋白2的非复制型重组腺病毒(Ad5F35-LMP2)修饰的DC能否在体内抑制肿瘤细胞生长.方法 人外周血单个核细胞在细胞因子IL-4、GM-CSF和TNF-a诱导下生成树突状细胞.将人的外周血单个核细胞移植入实验组SCID小鼠体内2次,再分别经两次DC与Ad5F35-LMP2-DC免疫SCID小鼠,然后用1×106的CNE-2肿瘤细胞接种SCID小鼠皮下,观察肿瘤生长情况.结果 Ad5F35-LMP2-DC组肿瘤的潜伏期明显延长,对照组和DC组小鼠1周左右就出现了肿瘤,而Ad5F35-LMP2-DC组则直到2周左右才出现肿瘤;且肿瘤体积最小,重量最轻,与DC组比Ad5F35-LMP2-DC疫苗组的肿瘤抑制率为64.75%.结论 Ad5F35-LMP2重组腺病毒疫苗修饰的DC在体内可以有效的抑制NPC肿瘤细胞CNE-2生长.
目的 瞭解含有EB病毒潛伏膜蛋白2的非複製型重組腺病毒(Ad5F35-LMP2)脩飾的DC能否在體內抑製腫瘤細胞生長.方法 人外週血單箇覈細胞在細胞因子IL-4、GM-CSF和TNF-a誘導下生成樹突狀細胞.將人的外週血單箇覈細胞移植入實驗組SCID小鼠體內2次,再分彆經兩次DC與Ad5F35-LMP2-DC免疫SCID小鼠,然後用1×106的CNE-2腫瘤細胞接種SCID小鼠皮下,觀察腫瘤生長情況.結果 Ad5F35-LMP2-DC組腫瘤的潛伏期明顯延長,對照組和DC組小鼠1週左右就齣現瞭腫瘤,而Ad5F35-LMP2-DC組則直到2週左右纔齣現腫瘤;且腫瘤體積最小,重量最輕,與DC組比Ad5F35-LMP2-DC疫苗組的腫瘤抑製率為64.75%.結論 Ad5F35-LMP2重組腺病毒疫苗脩飾的DC在體內可以有效的抑製NPC腫瘤細胞CNE-2生長.
목적 료해함유EB병독잠복막단백2적비복제형중조선병독(Ad5F35-LMP2)수식적DC능부재체내억제종류세포생장.방법 인외주혈단개핵세포재세포인자IL-4、GM-CSF화TNF-a유도하생성수돌상세포.장인적외주혈단개핵세포이식입실험조SCID소서체내2차,재분별경량차DC여Ad5F35-LMP2-DC면역SCID소서,연후용1×106적CNE-2종류세포접충SCID소서피하,관찰종류생장정황.결과 Ad5F35-LMP2-DC조종류적잠복기명현연장,대조조화DC조소서1주좌우취출현료종류,이Ad5F35-LMP2-DC조칙직도2주좌우재출현종류;차종류체적최소,중량최경,여DC조비Ad5F35-LMP2-DC역묘조적종류억제솔위64.75%.결론 Ad5F35-LMP2중조선병독역묘수식적DC재체내가이유효적억제NPC종류세포CNE-2생장.
Objective To observe whether dendritic cells(DCs) transfected with recombinant adenovirus Ad5F35-LMP2 suppress the proliferation of CNE-2 in vivo. Methods Dendritic cells have been generated with the induction of IL-4,GM-CSF and TNF-a in vitro. After human PBMCs were transplant into SCID mice,SCID mice were vaccinated with Ad5F35-LMP2-DC or untransfected DC. And four days latter,CNE-2 (1×106cell for each mouse) inoculated into SCID mouse subcutaneously. The tumor growth was monitored every week. Results The tumor latent period of Ad5F35-LMP2-DC group is longer among three groups. Untransfected DC group and CNE-2 positive control group could be found tumor about one week, but Ad5F35-LMP2-DC group was about two weeks. And the tumor was smaller and lighter than untransfected DC group and CNE-2 positive control group. Average tumor control rate reached 64.75% compared with untransfected DC group. Conclusion Ad5F35-LMP2-DC could effectively suppress the proliferation of CNE2 in vivo.